Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses.

Chen B, Vousden KA, Naiman B, Turman S, Sun H, Wang S, Vinall LMK, Kemp BP, Kasturiangan S, Rees DG, Grant E, Hinrichs MJ, Eck S, DiGiandomenico A, Jack Borrok M, Ly N, Xiong X, Gonzalez C, Morehouse C, Wang Y, Zhou Y, Cann J, Zhao W, Koelkebeck H, Okubo K, Mayadas TN, Howe D, Griffiths J, Kolbeck R, Herbst R, Sims GP.

Ann Rheum Dis. 2019 Feb;78(2):228-237. doi: 10.1136/annrheumdis-2018-213523. Epub 2018 Nov 20.

2.

Evidence for a direct link between PAD4-mediated citrullination and the oxidative burst in human neutrophils.

Zhou Y, An LL, Chaerkady R, Mittereder N, Clarke L, Cohen TS, Chen B, Hess S, Sims GP, Mustelin T.

Sci Rep. 2018 Oct 15;8(1):15228. doi: 10.1038/s41598-018-33385-z.

3.

Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus.

Riggs JM, Hanna RN, Rajan B, Zerrouki K, Karnell JL, Sagar D, Vainshtein I, Farmer E, Rosenthal K, Morehouse C, de Los Reyes M, Schifferli K, Liang M, Sanjuan MA, Sims GP, Kolbeck R.

Lupus Sci Med. 2018 Apr 5;5(1):e000261. doi: 10.1136/lupus-2018-000261. eCollection 2018.

4.

Perspective on Protein Arginine Deiminase Activity-Bicarbonate Is a pH-Independent Regulator of Citrullination.

Zhou Y, Mittereder N, Sims GP.

Front Immunol. 2018 Jan 18;9:34. doi: 10.3389/fimmu.2018.00034. eCollection 2018.

5.

Affinity maturation shapes the function of agonistic antibodies to peptidylarginine deiminase type 4 in rheumatoid arthritis.

Shi J, Darrah E, Sims GP, Mustelin T, Sampson K, Konig MF, Bingham CO 3rd, Rosen A, Andrade F.

Ann Rheum Dis. 2018 Jan;77(1):141-148. doi: 10.1136/annrheumdis-2017-211489. Epub 2017 Oct 25.

6.

Spontaneous Secretion of the Citrullination Enzyme PAD2 and Cell Surface Exposure of PAD4 by Neutrophils.

Zhou Y, Chen B, Mittereder N, Chaerkady R, Strain M, An LL, Rahman S, Ma W, Low CP, Chan D, Neal F, Bingham CO 3rd, Sampson K, Darrah E, Siegel RM, Hasni S, Andrade F, Vousden KA, Mustelin T, Sims GP.

Front Immunol. 2017 Sep 25;8:1200. doi: 10.3389/fimmu.2017.01200. eCollection 2017.

7.

Aging and Systemic Lupus Erythematosus - Immunosenescence and Beyond.

van den Hoogen LL, Sims GP, van Roon JA, Fritsch-Stork RD.

Curr Aging Sci. 2015;8(2):158-77. Review.

PMID:
26212055
8.

Characterization of the Hypercitrullination Reaction in Human Neutrophils and Other Leukocytes.

Zhou Y, Di Pucchio T, Sims GP, Mittereder N, Mustelin T.

Mediators Inflamm. 2015;2015:236451. doi: 10.1155/2015/236451. Epub 2015 May 19.

9.

S100A9 induced inflammatory responses are mediated by distinct damage associated molecular patterns (DAMP) receptors in vitro and in vivo.

Chen B, Miller AL, Rebelatto M, Brewah Y, Rowe DC, Clarke L, Czapiga M, Rosenthal K, Imamichi T, Chen Y, Chang CS, Chowdhury PS, Naiman B, Wang Y, Yang D, Humbles AA, Herbst R, Sims GP.

PLoS One. 2015 Feb 23;10(2):e0115828. doi: 10.1371/journal.pone.0115828. eCollection 2015.

10.

RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA.

Sirois CM, Jin T, Miller AL, Bertheloot D, Nakamura H, Horvath GL, Mian A, Jiang J, Schrum J, Bossaller L, Pelka K, Garbi N, Brewah Y, Tian J, Chang C, Chowdhury PS, Sims GP, Kolbeck R, Coyle AJ, Humbles AA, Xiao TS, Latz E.

J Exp Med. 2013 Oct 21;210(11):2447-63. doi: 10.1084/jem.20120201. Epub 2013 Sep 30. Erratum in: J Exp Med. 2014 May 5;211(5):1001.

11.

RAGE inhibits human respiratory syncytial virus syncytium formation by interfering with F-protein function.

Tian J, Huang K, Krishnan S, Svabek C, Rowe DC, Brewah Y, Sanjuan M, Patera AC, Kolbeck R, Herbst R, Sims GP.

J Gen Virol. 2013 Aug;94(Pt 8):1691-700. doi: 10.1099/vir.0.049254-0. Epub 2013 Apr 4.

12.

Opposing roles of membrane and soluble forms of the receptor for advanced glycation end products in primary respiratory syncytial virus infection.

Miller AL, Sims GP, Brewah YA, Rebelatto MC, Kearley J, Benjamin E, Keller AE, Brohawn P, Herbst R, Coyle AJ, Humbles AA, Kolbeck R.

J Infect Dis. 2012 Apr 15;205(8):1311-20. doi: 10.1093/infdis/jir826. Epub 2012 Jan 18.

13.

A glycoengineered anti-CD19 antibody with potent antibody-dependent cellular cytotoxicity activity in vitro and lymphoma growth inhibition in vivo.

Ward E, Mittereder N, Kuta E, Sims GP, Bowen MA, Dall'Acqua W, Tedder T, Kiener P, Coyle AJ, Wu H, Jallal B, Herbst R.

Br J Haematol. 2011 Nov;155(4):426-37. doi: 10.1111/j.1365-2141.2011.08857.x. Epub 2011 Sep 9.

PMID:
21902688
14.

Isolation of human B cell populations.

Heine G, Sims GP, Worm M, Lipsky PE, Radbruch A.

Curr Protoc Immunol. 2011 Aug;Chapter 7:Unit7.5. doi: 10.1002/0471142735.im0705s94.

PMID:
21809320
15.

Emerging small molecule and biological therapeutic approaches for the treatment of autoimmunity.

Leishman AJ, Sims GP, Sleeman M, Braddock M.

Expert Opin Investig Drugs. 2011 Jan;20(1):23-39. doi: 10.1517/13543784.2011.540569. Epub 2010 Dec 1. Review.

PMID:
21118058
16.

B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody.

Herbst R, Wang Y, Gallagher S, Mittereder N, Kuta E, Damschroder M, Woods R, Rowe DC, Cheng L, Cook K, Evans K, Sims GP, Pfarr DS, Bowen MA, Dall'Acqua W, Shlomchik M, Tedder TF, Kiener P, Jallal B, Wu H, Coyle AJ.

J Pharmacol Exp Ther. 2010 Oct;335(1):213-22. doi: 10.1124/jpet.110.168062. Epub 2010 Jul 6. Erratum in: J Pharmacol Exp Ther. 2011 Jan;336(1):294. Dall'Aqua, William [corrected to Dall'Acqua, William].

PMID:
20605905
17.

HMGB1 and RAGE in inflammation and cancer.

Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ.

Annu Rev Immunol. 2010;28:367-88. doi: 10.1146/annurev.immunol.021908.132603. Review.

PMID:
20192808
18.

Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.

Ferhani N, Letuve S, Kozhich A, Thibaudeau O, Grandsaigne M, Maret M, Dombret MC, Sims GP, Kolbeck R, Coyle AJ, Aubier M, Pretolani M.

Am J Respir Crit Care Med. 2010 May 1;181(9):917-27. doi: 10.1164/rccm.200903-0340OC. Epub 2010 Feb 4.

PMID:
20133931
19.

Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in three-dimensional organ culture.

Kiener HP, Watts GF, Cui Y, Wright J, Thornhill TS, Sköld M, Behar SM, Niederreiter B, Lu J, Cernadas M, Coyle AJ, Sims GP, Smolen J, Warman ML, Brenner MB, Lee DM.

Arthritis Rheum. 2010 Mar;62(3):742-52. doi: 10.1002/art.27285.

20.

Innate immune signals modulate antiviral and polyreactive antibody responses during severe respiratory syncytial virus infection.

Reed JL, Welliver TP, Sims GP, McKinney L, Velozo L, Avendano L, Hintz K, Luma J, Coyle AJ, Welliver RC Sr.

J Infect Dis. 2009 Apr 15;199(8):1128-38. doi: 10.1086/597386.

PMID:
19278337
21.

Genomic-based high throughput screening identifies small molecules that differentially inhibit the antiviral and immunomodulatory effects of IFN-alpha.

Chen B, Zong Q, Cibotti R, Morris C, Castaneda J, Naiman B, Liu D, Glodek A, Sims GP, Herbst R, Horrigan SK, Kiener PA, Soppet D, Coyle AJ, Audoly L.

Mol Med. 2008 Jul-Aug;14(7-8):374-82. doi: 10.2119/2008-00028.Chen.

22.

Isolation of human B cell populations.

Sims GP, Lipsky PE.

Curr Protoc Immunol. 2006 Dec;Chapter 7:Unit 7.5. doi: 10.1002/0471142735.im0705s75.

PMID:
18432976
23.

Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration.

Kuchen S, Robbins R, Sims GP, Sheng C, Phillips TM, Lipsky PE, Ettinger R.

J Immunol. 2007 Nov 1;179(9):5886-96.

24.

Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.

Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE.

J Immunol. 2007 Aug 1;179(3):1634-47.

25.

IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells.

Ettinger R, Sims GP, Robbins R, Withers D, Fischer RT, Grammer AC, Kuchen S, Lipsky PE.

J Immunol. 2007 Mar 1;178(5):2872-82.

26.

IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells.

Ettinger R, Sims GP, Fairhurst AM, Robbins R, da Silva YS, Spolski R, Leonard WJ, Lipsky PE.

J Immunol. 2005 Dec 15;175(12):7867-79.

27.

Developmental changes in the human heavy chain CDR3.

Souto-Carneiro MM, Sims GP, Girschik H, Lee J, Lipsky PE.

J Immunol. 2005 Dec 1;175(11):7425-36.

28.

Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27.

Fritsch RD, Shen X, Sims GP, Hathcock KS, Hodes RJ, Lipsky PE.

J Immunol. 2005 Nov 15;175(10):6489-97.

29.

Identification and characterization of circulating human transitional B cells.

Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE.

Blood. 2005 Jun 1;105(11):4390-8. Epub 2005 Feb 8.

30.

Scenarios for autoimmunization of T and B cells in myasthenia gravis.

Shiono H, Roxanis I, Zhang W, Sims GP, Meager A, Jacobson LW, Liu JL, Matthews I, Wong YL, Bonifati M, Micklem K, Stott DI, Todd JA, Beeson D, Vincent A, Willcox N.

Ann N Y Acad Sci. 2003 Sep;998:237-56.

PMID:
14592881
31.

Identification and phylogenetic analysis of morphologically similar naked amoebae using small subunit ribosomal RNA.

Sims GP, Aitken R, Rogerson A.

J Eukaryot Microbiol. 2002 Nov-Dec;49(6):478-84.

PMID:
12503684
32.
35.

Race, class, and gender considerations in nursing education.

Sims GP, Baldwin D.

N HC Perspect Community. 1995 Nov-Dec;16(6):316-21. Review. No abstract available.

PMID:
8705647
36.

An interactive model of leadership.

Kosowski MM, Grabbe L, Grams K, Lobb MO, Willoughby DF, Davis SP, Sims GP.

Nurs Adm Q. 1990 Fall;15(1):36-43. No abstract available.

PMID:
2234533

Supplemental Content

Support Center